The only drugs proven to induce regression of the disease are the immunomodulatory agents interferon-α (MRC Renal Cancer Collaborators, 1999) and interleukin-2 (IL-2) (Yang et al, 2003). The gene discussed is IL2; the disease is renal carcinoma.